Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | +17.86% | 0.00% | +9.27% |
May. 08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
Performance
1 day | +17.86% | ||
Current month | +17.86% | ||
1 month | +14.58% | ||
3 months | +11.11% | ||
6 months | +17.02% | ||
Current year | +9.27% | ||
1 year | -3.50% | ||
3 years | -66.05% | ||
5 years | -77.55% | ||
10 years | -90.98% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Specialty & Advanced Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+17.86% | 0.00% | +9.27% | -3.50% | 63.85M | ||
-1.41% | -1.02% | +10.44% | -4.99% | 9.08B | ||
+2.40% | +0.11% | -10.76% | +26.38% | 5.06B | ||
-0.49% | +4.89% | +53.60% | +135.17% | 4.85B | ||
+5.87% | +2.07% | +7.56% | +34.90% | 3.85B | ||
-2.38% | -5.26% | +14.09% | -7.78% | 2.37B | ||
-0.71% | -6.23% | -21.42% | -38.80% | 2.36B | ||
+0.33% | +4.17% | +25.03% | +0.91% | 2.27B | ||
-1.57% | -8.44% | -30.36% | -45.33% | 2.22B | ||
-.--% | -.--% | - | - | 1.64B | ||
+1.46% | -2.80% | +0.76% | -17.06% | 1.58B | ||
-5.28% | -8.77% | +1.41% | -2.67% | 1.33B | ||
+0.59% | -1.95% | -18.22% | -26.81% | 1.05B | ||
-0.32% | -2.80% | +1.29% | +4.96% | 891M | ||
+2.32% | +6.92% | +34.06% | +38.88% | 852M | ||
-2.89% | -6.85% | -41.16% | -49.59% | 850M | ||
Average | +0.99% | -1.44% | +2.37% | +2.98% | ||
Weighted average by Cap. | +0.15% | -0.92% | +7.28% | +15.68% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +9.27% | ||
2023 | -12.72% | ||
2022 | -56.86% | ||
2021 | -25.74% | ||
2020 | -18.18% | ||
2019 | +5.60% | ||
2018 | +41.40% | ||
2017 | +6.51% | ||
2016 | -40.71% | ||
2015 | -65.52% | ||
2014 | -20.39% | ||
2013 | +2.86% |
- Stock Market
- Equities
- ORX Stock
- ORXO.Y Stock
- Quotes Orexo AB